Dr. Julie Ducharme is a dynamic leader, keynote speaker, national best-selling author, professor, and serial entrepreneur with over 20 years of experience in empowering others. She is the visionary behind the Lead and Empower Her SHE Talks movement, a nationwide women’s empowerment conference that provides women with platforms to speak, write, and inspire others. As the founder of JD Consulting, she helps businesses scale and increase brand visibility through creative, viral marketing campaigns. Dr. Ducharme is also deeply committed to education, actively shaping future leaders as a professor and championing youth as the future of this world. With her focus on leadership, business strategy, and female empowerment, she is a sought-after speaker, advisor, and thought leader, working to inspire and empower through her ventures and publications.

Daniela is dedicated to empowering early-stage startups by providing strategic insights, funding guidance, and hands-on mentorship. With a deep understanding of business development and scaling operations, she helps founders navigate the complexities of growing their businesses in highly competitive markets. Passionate about identifying disruptive startups with high growth potential, she works closely with them to refine their business models, develop scalable strategies, and secure the necessary resources to thrive. Her mission is to bridge the gap between visionary founders and the capital and networks they need to succeed. She is a hard-working, dynamic, and determined person who strongly believes in transparency, clarity, loyalty, and competence, and she has based her professional career on these values.

‍

Kadambari Beelwar, CEO, Truss Health has managed digital health technology group at Stanford Children’s Medical Health growing their telehealth program by 4000%. Her efforts earned Stanford Children’s Medical Health, eHealthcare Leadership award for “Best Overall Digital Patient Experience”. Her previous experience includes Kaiser Permanente where she led KP’s biggest technology acquisition with Group Healthcare that included 55+ clinics in Washington state, Maui Memorial and Emory Healthcare partnership with Kaiser Permanente. She has also earned her master’s in electrical engineering and executive master’s in business administration from Wharton, University of Pennsylvania.

Athena is a Healthcare Investor based out of B Capital’s San Francisco office, where she focuses on opportunities in Digital Health and Healthcare IT. She has dedicated time to sectors including, but not limited to, women’s health, new models of care delivery, the intersection of healthcare and fintech, revenue cycle management, and real-world evidence. Athena is a New York native that graduated from Cornell University with a B.S. in Policy Analysis and Management with a concentration in Healthcare Economics.

Kristen Schultz is the founder and CEO of Woodland Strategic Advisors, a boutique strategy consulting firm focused on advancing innovation, growth and financial sustainability in women’s health. With 20 years of experience in healthcare consulting, nonprofit leadership, and operational transformation, Kristen specializes in helping mission-driven organizations achieve operational excellence and lasting success. Previously, Kristen served as Chief Strategy & Operations Officer at Planned Parenthood of Illinois, leading the operations of 18 health centers and telehealth platforms. During her tenure she drove substantial growth in revenue and patient access, leading to the largest patient increase of any state in the U.S. during the loss of federal abortion protection. Kristen spearheaded initiatives to improve health equity, clinical quality, and financial viability. Kristen also has extensive experience in healthcare consulting from her time at Deloitte, where she led complex strategy projects for Fortune 500 companies, focusing on long-term growth strategies, healthcare service expansion, and the development of innovative operating models. In addition to her professional roles, Kristen served on the board of BetterHealth, contributing to governance, strategy and technological advancement for Planned Parenthood affiliates nationwide. Kristen earned an MBA and an MPP from the University of Michigan, and a BA in Gender Studies from the University of Southern California. Kristen lives in the Chicago area with her husband and three children. She is driven by a passion for health equity and organizational impact, leveraging her skills to empower mission-driven organizations to navigate challenges, innovate effectively, and thrive in the ever-evolving healthcare ecosystem.

Jessica Zoraida is a seasoned Latina entrepreneur who actively empowers marginalized people especially women through employment, mentorship, service to community and regular programming that simplifies financial topics so that fear and confusion are eliminated, making way for empowerment and success. Her story is one of overcoming adversity throughout her life - Bronx born, poor, first to go to college, navigated a11 year career in Corporate Banking, 15 years as entrepreneur and is an active member and volunteer in women centric organizations.

Today, Jessica is CEO of Big Picture Results Inc., an Accounting and Tax company that helps growing companies bring more to the bottom line, is a speaker and subject matter expert, and investor in women/PoCowned companies. An avid traveler, active and living joyfully, she walks the walk and is eager to share strategies and tools that allow us to live our best life as entrepreneurs.

Melissa is an SVP with HSBC Innovation Banking, HSBC’s startup and VC banking arm. Melissa focuses on SoCal innovation, supporting the local venture ecosystem with banking solutions, debt, connectivity and more. Prior to HSBC, she worked in venture capital, supporting founders in the Clocktower Ventures and M13 portfolios. She is passionate about making a positive impact on the world through supporting incredible entrepreneurs.

Over a decade of experience in the sciences including epidemiology, data science, statistical programming, pharmacovigilance and drug safety, medical device research, infectious disease surveillance, immunology laboratory research, as well as direct patient care. Epidemiology experience in academia (University of Utah, University of Pittsburgh, Harvard School of Public Health), Allegheny County health department, multiple start-up companies, pharma/biotechnology companies (Amgen, Sanofi, Regeneron, Roche), healthtech (lunit.io), medical devices (Johnson & Johnson), and consulting. Spent many years working and studying in Europe (Bamberg, Halle, Leipzig, Madrid, and Munich). Currently a co-founder of two AI-driven products in the life sciences: a predictive analytics SaaS platform designed for pharma and biotech companies in market access, and a collaborative (open science) research tool aimed at enhancing the quality and rigor of observational research studies.

Dr. Beata Mierzwa is a cancer researcher and founder of Beata Science Art, which aims to share the beauty of science through art, fashion, and interactive media. After having worked on cytokinetic abscission during her PhD, Beata's current research at the University of California San Diego focuses on understanding mechanisms of cell division and the p53 pathway to improve cancer therapy. Beyond her academic career, Beata explores various approaches to visual science communication, using hand-drawn illustration, science-themed clothing, and a cell biology video game titled Microscopya to communicate science inside and outside the scientific community. Through her AAAS IF/THEN Ambassadorship she aims to inspire students to pursue careers in STEM and empower our next generation of creative scientists. For more information, please visit www.beatascienceart.com or follow @beatascienceart on social media.

Vidya is a health/biotech product and commercial strategy executive with 15+ years of experience building,launching and scaling products across GRAIL, Exact Sciences, Genomic Health and Thermo Fisher Scientific.

Her mission and passion has been centered around leading the development of innovative products and their go-to-market strategies to improve patient outcomes on a global scale.

She is currently the chief product and strategy officer for a stealth mode longevity startup, with a mission to democratize HealthSpan testing and services with personalized care pathways, for all. Vidya is deeply passionate about supporting female founders and in addition to being an active mentor to several female founders, she is an LP in the Portfolia FemTech fund and the Neythri Futures Fund.

‍

Joe is the managing partner at SeedFolio, a seed-stage VC focused primarily on life sciences. Prior to SeedFolio, he was the founder and CEO of StarMine which he grew until a successful exit.

Olga Grygoryan is the Founder & CEO of Sybil Health, bringing over 18 years of leadership and technical expertise in IT, AI, and data science, with hands-on experience at leading biopharma and medical device companies like Medtronic, Amgen, and Janssen Pharmaceuticals. Committed to innovation in women’s health, she harnesses data-driven personalization and empathetic design to transform hormonal healthcare. Her mission is to deliver impactful solutions that address mid-life hormonal shifts, bridging critical gaps and ultimately redefining women’s health through technology.

Dr. Libia F. Scheller is a renowned entrepreneur, health futurist, & leader in biotech & pharmaceuticals. She holds a BS in Genetics from Yale University School of Medicine, a PhD in Immunology from the University of Maryland, & an MBA in International Management of Science from Basel, Switzerland. Her postdoctoral work at the Naval Medical Research Institute focused on vaccine development, and she has pursued advanced training in Oncology Nutrition, AI in Healthcare & the impact of Quantum AI in healthcare Dr. Scheller achieved two successful biotech exits early in her career before transitioning to leadership roles in the pharmaceutical industry, including positions at Sanofi-Aventis and Bayer Healthcare, as the Global Oncology Head of Strategic Alliances. She also is an advisor & serves on multiple biotech boards & actively invests in innovative technologies. M.I.A.M.I. AI Ventures provides business development and access to capital for startup companies focusing on HealthTech, diagnostics, & longevity medicine. Passionate about innovation, she leverages her expertise in emerging technologies, including cognitive and quantum AI, to shape the future of healthcare.Dr. Libia F. Scheller is a renowned entrepreneur, health futurist, & leader in biotech & pharmaceuticals. She holds a BS in Genetics from Yale University School of Medicine, a PhD in Immunology from the University of Maryland, & an MBA in International Management of Science from Basel, Switzerland. Her postdoctoral work at the Naval Medical Research Institute focused on vaccine development, and she has pursued advanced training in Oncology Nutrition, AI in Healthcare & the impact of Quantum AI in healthcare Dr. Scheller achieved two successful biotech exits early in her career before transitioning to leadership roles in the pharmaceutical industry, including positions at Sanofi-Aventis and Bayer Healthcare, as the Global Oncology Head of Strategic Alliances. She also is an advisor & serves on multiple biotech boards & actively invests in innovative technologies. M.I.A.M.I. AI Ventures provides business development and access to capital for startup companies focusing on HealthTech, diagnostics, & longevity medicine. Passionate about innovation, she leverages her expertise in emerging technologies, including cognitive and quantum AI, to shape the future of healthcare.

Dr. Anh Hoang-Lindsay is the CEO of Jana Care Inc, a pioneering developer of at-home, self-administered blood testing technologies for heart disease and chronic kidney disease management. The platform enables patients to self-administer blood tests at-home and allows clinicians to review the test results remotely as needed. Outside of Jana Care, Anh is a part time faculty at Massachusetts Institute of Technology(MIT)’s Catalyst Program, a member of the board of directors of MassMedic, and serves as an advisor/board member to several early stage companies, research institutions, and venture capital funds. Anh completed her doctorate degree (Ph.D) in material science engineering from Vanderbilt University and her postdoctoral fellowship at Harvard Medical School and Mass General Hospital as an Executive Committee on Research fellow.

Vrinda Agarwal is a VC investor based in San Francisco, focused on early stage B2B investing. With a background spanning venture capital, technology product strategy, and investment banking, she brings expertise in helping startups navigate growth and scale. Prior to her career in venture capital investing, Vrinda worked in Product Strategy & Finance at Google, and in investment banking at Goldman Sachs.

Vrinda received her MBA from Harvard Business School. She holds dual degrees in Political Science and Development Economics from UC Berkeley, where she graduated as departmental valedictorian. Passionate about mentorship and building inclusive ecosystems, she actively supports emerging entrepreneurs and women in business.

‍

Jami DeBrango-Palumbo, CEO of SIH Consulting LLC, is a visionary healthcare executive, author, industry strategist, and expert in operationalizing strategy, with over 25 years of global leadership in pharmaceuticals, biotechnology, and molecular diagnostics. She has held progressively senior roles at Idec Pharmaceuticals, Biogen, Genentech, Roche, and Foundation Medicine, and is currently serving as EVP at Harbinger Health, where she is driving strategic workforce planning and ensuring scalable organizational and operational frameworks to enhance efficiency, foster innovation, and drive operational impact.

Jami has played a pivotal role in the global launch of industry-defining therapies, including Rituximab®, Avastin®, Herceptin®, and Tamiflu®. Her expertise in precision medicine, next-generation sequencing, and strategic workforce planning has consistently driven the advancement of cutting-edge treatments and reshaped the landscape of personalized healthcare.

Her leadership is rooted in a commitment to people and processes, mentoring emerging leaders, nurturing organizational cultures, and fostering innovation within high-performing teams. Known for turning strategy into execution and operational excellence Jami thrives in guiding teams through complex challenges and scaling transformative ideas into industry-defining solutions.

Jami has recently been recognized as a finalist for Women of Influence in Science by the San Diego Business Journal and has received several leadership awards throughout her career, further highlighting her dedication and contributions to the healthcare and science industries. She is also the founder of "Strength in Heels®", a trademarked movement and author designed to inspire resilience and empower leadership. Additionally, she co-founded Kristin’s Fund, a 501c(3) nonprofit dedicated to combating domestic violence, turning personal adversity into a global force for positive change.

She also serves as Advisory Board Member at the Medical University of South Carolina (MUSC), since 2011, and is passionate about expanding healthcare access and advancing global health equity.

Jami is a highly sought-after industry expert, mentor, and advocate, her career is a testament to bold, courageous leadership, transformative execution, and an unwavering commitment to advancing science for the benefit of patients worldwide.

‍

As a Founder, GTM leader and community builder, Livia has firsthand experience building and scaling healthcare solutions, including co-founding Compass, a mental health platform focused on personalized care navigation. Her experience expanding into Life Sciences at a Series D scale up, combined with her active role fostering connections between entrepreneurs, investors, and healthcare leaders through her newsletter LIVTOSHARE and organization of over 100+ community events, gives her unique insight into the challenges and opportunities in healthcare innovation and the women's health ecosystem.